Adapt, innovate, and scale for the future
At a turning point in clinical trial transformation, large biopharma companies rely on Medidata to adapt, scale, and realize their next breakthrough.
Why Large Biopharma Companies Trust Medidata
Large biopharma players are under pressure to adapt to disruptions, respond to patient centricity, detect risks earlier, and scale at an unprecedented pace to get therapies to market faster.
With 20+ years of industry leadership, Medidata empowers 19 of the top 20 biopharma companies to meet the demands and opportunities of every trial environment.
INNOVATE WITH PROVEN TECHNOLOGY
Unify the latest digital technologies, new data sources, and advanced analytics, to realize your next breakthrough and propel your growth.
ADAPT TO ANYTHING
Respond to changing needs or new opportunities. Adapt to new challenges, integrate new technologies, and meet patient expectations.
BUILD FOR THE FUTURE
Stay ahead of new disruptions, trends, and innovations. Invest in the technology that meets today’s opportunities and tomorrow’s transformation.
One technology platform to power people, processes, and progress.
Medidata helps you adapt, simplify, scale, and accelerate your clinical trials, from protocol design to study startup, conduct, close-out, and commercialization.
Our platform is built to enable you with cloud-based, modular, integrable, easily configurable capabilities, all powered by the latest patient, clinical and operational data, and AI solutions.
The industry’s only complete decentralized clinical trial solution
You don’t just need a decentralized clinical trial solution. You need a partner who understands your specific needs as a large Biopharma and has proven capabilities with large studies, a completely unified platform, and offers data security, privacy, and compliance.
Truth in data:
- 800+ studies, 600K+ patients, 44K+ sites using a Medidata DCT solution
- All top 10 pharma have used Medidata’s DCT solutions
Read more about our end-to-end decentralized clinical trials for large biopharma.
The industry’s only platform to leverage cross-industry clinical trial data
You operate in a high risk, continuously evolving clinical development landscape. Navigate that landscape with actionable insights and data-driven decisions for safer, stronger, and better clinical trials.
Truth in data:
- Clinical trial data from 7 million patients and 25,000+ trials
- 45B+ data points
- 63% growth in data volume in 4 years
Learn more about our data and analytics solutions for large biopharma.
The results-driven approach to unifying teams, data, and processes
Outgrown your current IT infrastructure? For large biopharma, Medidata offers a solution flexible enough to work with your existing systems and powerful enough to ingest new data sources, decentralizing elements of your trial with ease – so you can quickly optimize trial performance.
Truth in data:
- 5 days to reach database lock
- 80% reduction in data correction rates
- 40% reduction in edit checks
Learn more about our unified technology platform for large biopharma.
The industry’s most comprehensive patient-centric solutions
For large biopharma, trial success hinges on finding the right patients and keeping them engaged pre, during, and post trial. Our patient-centric solutions reduce patient burden, increase patient safety, and drive patient diversity – with a seamless, intuitive, and accessible patient experience.
Truth in data:
- Cross-industry clinical trial data from over 25,000 trials and over 7 million patients
- Datasets pre-integrated with real world data
Learn more about our patient-centric clinical trial solutions for large biopharma.
